WuXi Biologics (Cayman) Inc.
WXIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,339,266 | $3,335,318 | $1,499,080 | $1,699,865 |
| Dep. & Amort. | $854,474 | $653,262 | $783,792 | $584,688 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $468,854 | $525,446 | $690,141 | $637,026 |
| Change in WC | $0 | -$800,504 | $0 | -$448,173 |
| Other Non-Cash | -$1,855,840 | $201,616 | -$1,670,894 | -$139,550 |
| Operating Cash Flow | $1,806,754 | $3,915,138 | $1,302,119 | $2,333,856 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,900,414 | -$2,062,237 | -$1,867,384 | -$2,022,787 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$11,429,271 | $0 | -$7,541,510 |
| Inv. Sales/Matur. | $0 | $10,892,906 | $0 | $7,819,169 |
| Other Inv. Act. | $1,362,207 | -$960,579 | $1,484,859 | $130,995 |
| Investing Cash Flow | -$538,207 | -$3,559,181 | -$382,525 | -$1,614,133 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,089 | $490,101 | -$69,508 | -$409,225 |
| Stock Issued | $0 | $19,392 | $0 | $13,079 |
| Stock Repurch. | -$1,031,664 | -$531,556 | -$1,234,390 | -$458,458 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$55,991 | -$1,252,544 | -$171,686 | $3,016,890 |
| Financing Cash Flow | -$1,085,566 | -$1,274,607 | -$1,475,584 | $2,149,207 |
| Forex Effect | -$23,105 | $44,304 | $39,679 | -$62,996 |
| Net Chg. in Cash | $8,439,058 | $8,537,338 | -$258,156 | $3,274,617 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | -$258,156 | $0 | $6,395,222 |
| End Cash | $8,439,058 | $8,279,182 | -$258,156 | $9,669,839 |
| Free Cash Flow | -$93,660 | $1,852,901 | -$565,265 | $218,599 |